Authors:
Ponec, D
Irwin, D
Haire, WD
Hill, PA
Li, X
McCluskey, ER
Citation: D. Ponec et al., Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: A double-blind placebo-controlled trial - The cardiovascular thrombolytic to open occluded lines (COOL) efficacy trial, J VAS INT R, 12(8), 2001, pp. 951-955
Citation: Ch. Pui et al., Recombinant urate oxidase (rasburicase) in the prevention and treatment ofmalignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial, LEUKEMIA, 15(10), 2001, pp. 1505-1509
Citation: Af. Carson et al., A comparison of Scottish Blackface and Cheviot ewes and five sire breeds in terms of lamb output at weaning in hill sheep systems, J AGR SCI, 137, 2001, pp. 221-233
Authors:
Damon, LE
Hu, WW
Stockerl-Goldstein, KE
Blume, KG
Wolf, JL
Gold, E
Cecchi, GR
Irwin, D
Glaspy, J
Territo, M
Miller, W
Mason, JR
Linker, CA
Citation: Le. Damon et al., High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: Experience in California, BIOL BLOOD, 6(5), 2000, pp. 496-505
Authors:
Taube, R
Fujinaga, K
Irwin, D
Wimmer, J
Geyer, M
Peterlin, BM
Citation: R. Taube et al., Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1, J VIROLOGY, 74(2), 2000, pp. 892-898